Concepedia

Tuba N. Gide

TN

Statistics

Publications

16

Citations

3.3K

H-Index

15

Active since

2017

Affiliations

Royal North Shore Hospital(Current)

Royal Prince Alfred Hospital

The University of Sydney

Melanoma Institute Australia

Blacktown & Mount Druitt Hospital

Tuba N. Gide is an author at Royal North Shore Hospital specializing in oncology, immunology, and immunotherapy.

ORCID

Publications per year

2017–2025

16

Publications

16

Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy

Tuba N. Gide, Camelia Quek, Alexander M. Menzies et al. · Cancer Cell · 2019 · 1K citations · Full text

, , +17

Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade

Imran G. House, Peter Savas, Junyun Lai et al. · Clinical Cancer Research · 2019 · 766 citations

, , +17

CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment

Jarem Edwards, James S. Wilmott, Jason Madore et al. · Clinical Cancer Research · 2018 · 441 citations

, , +17

Circulating Cytokines Predict Immune-Related Toxicity in Melanoma Patients Receiving Anti-PD-1–Based Immunotherapy

Su Yin Lim, Jenny Lee, Tuba N. Gide et al. · Clinical Cancer Research · 2018 · 368 citations

, , +17

Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients

Hojabr Kakavand, Louise Jackett, Alexander M. Menzies et al. · Modern Pathology · 2017 · 220 citations · Full text

, , +16

1–5 of 16